Zai Lab Limited (NASDAQ: ZLAB) is making strides in the biopharmaceutical sector, recently highlighted as a notable growth stock. The company has entered
Category: Antibody Drug Conjugates
Boehringer Ingelheim and Zai Lab Collaborate on DLL3-Targeting Therapy for Lung Cancer
Boehringer Ingelheim and Zai Lab have embarked on an innovative clinical partnership aimed at exploring a dual approach to targeting delta like ligand 3
Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreement
डुअलिटी बायोलॉजिक्स ने एडसेंडो एपीएस सहयोग का विस्तार किया डुअलिटी बायोलॉजिक्स ने हाल ही में एडसेंडो एपीएस के साथ अपने सहयोग का विस्तार करने की घोषणा की
MacroGenics Investors Eye Critical 2026 Clinical Milestones
MacroGenics Yatırımcılarının 2026 Klinik Dönüm Noktalarına Dikkati Bioteknoloji yatırımcıları, MacroGenics’in antikor ilaç konjugatları (ADC’ler) ve iki
Precision Engineering Defines Next-Gen ADC
الهندسة الدقيقة تحدد مستقبل عقاقير ADC تعتبر عقاقير الأجسام المضادة المرتبطة بالأدوية (ADCs) فئة متطورة بسرعة من العلاجات المستهدفة في مجال الأورام، حيث
Kelun-Biotech’s SKB103 Gains NMPA Approval: A Leap Forward in Oncology
Kelun Biotech has achieved a significant milestone with the approval of its investigational new drug (IND) application for SKB103, a groundbreaking
The Pivotal Role of Payload Linkers in Advancing Antibody-Drug Conjugates
The evolution of antibody drug conjugates (ADCs) has revolutionized targeted cancer therapy. At the heart of this innovation lies the payload linker, a
Navigating the Complexities of ADC Production
Antibody drug conjugates (ADCs) represent a cutting edge approach in oncology, merging the specificity of antibodies with the therapeutic power of small
Enhanced Radiation Surveillance with Raybird UAS
The landscape of environmental monitoring has taken a significant leap forward with the integration of a radiation sensor payload into the Raybird